Today, the Commission is proposing to revise the EU's pharmaceutical legislation - the largest reform in over 20 years - to make it more agile, flexible, and adapted to the needs of citizens and businesses across the EU. The revision will make medicines more available, accessible and affordable. It will support innovation and boost the competitiveness and attractiveness of the EU pharmaceutical industry, while promoting higher environmental standards. In addition to this reform, the Commission proposes a Council Recommendation to step up the fight against antimicrobial resistance (AMR).
Commission proposes pharmaceuticals reform for more accessible, affordable and innovative medicines
31.08.2023 - 21:00
BGNES
Watch and Comment news
Pig kidney transplanted to American in Massachusetts
08.02.2025 - 07:15
Blueberries - a natural assistant in the fight against aging
31.01.2025 - 08:47
Intensive marijuana use may affect short-term memory in the youth
30.01.2025 - 18:17
Mental health problems among young people up 65% in 10 years
29.01.2025 - 08:59
6 dangerous walking habits that damage knees
28.01.2025 - 06:46